For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...

Implantation of an S-ICD in a Patient with a DDD Pacemaker and Congenitally Corrected Transposition of the Great Arteries In a new publication from Cardiovascular ...

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...

Washington, DC - Despite the vast improvement in mortality for those implanted with a device, the ICD population of the Multicenter Autonomic Defibrillator Implantation Trial II (MADIT II) had a ...

SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...

Patients with an indication for an implantable cardiac defibrillator for primary prevention of sudden cardiac death and a sharply reduced left ventricular ejection fraction of 35% or less safely ...

The overall primary composite endpoint of inappropriate shocks and complications came out nearly identical (HR 0.99, 95% CI 0.71-1.39, P=0.01 for noninferiority) over a median 4 years in the ...

Take a moment to reflect on clinical documentation practice over the past decade. A tremendous amount of progress has been made advancing the capture, analysis and distribution of information, and ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In certain patients with an ICD for primary prevention, ...